Newsbenzinga
Novo Nordisk CEO Hints Semaglutide Could Be More Than A Weight-Loss Drug: 'A Bit Of A Longevity Game'
· Published
Article summary
Novo Nordisk exploring additional uses for obesity drug semaglutide, including potential for longevity and aesthetics.
An excerpt from the original article.
Comments —
Loading comments…